Form 4 Tracker
Prelude Therapeutics Inc
PRLD

15 insider filings · Latest: Jun 9, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Apr 21, 2026Apr 23 10:50 PMDavid P BonitaDirector, 10% Owner
Purchase
2,815,315$4.44$12.5M1,126,126(I)

View →

Apr 21, 2026Apr 23 10:48 PMORBIMED ADVISORS LLCDirector, 10% Owner
Purchase
2,815,315$4.44$12.5M1,126,126(I)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 9, 2026Jun 10 8:44 PMBAKER BROS. ADVISORS LPDirector, 10% Owner
Grant/Award
76,000$3.9438,000(I)

View →

Jun 9, 2026Jun 10 8:15 PMKatina DortonDirector
Grant/Award
38,000$3.9438,000(D)

View →

Jun 9, 2026Jun 10 8:15 PMMartin BablerDirector
Grant/Award
38,000$3.9438,000(D)

View →

Jun 9, 2026Jun 10 8:13 PMDavid P BonitaDirector, 10% Owner
Grant/Award
38,000$3.9438,000(D)

View →

Jun 9, 2026Jun 10 8:13 PMVictor SandorDirector
Grant/Award
38,000$3.9438,000(D)

View →

Jun 9, 2026Jun 10 8:12 PMPaul A FriedmanDirector
Grant/Award
38,000$3.9438,000(D)

View →

May 1, 2026May 4 8:10 PMCharles Q MorrisChief Medical Officer
Grant/Award
450,000$4.70450,000(D)

View →

Apr 27, 2026Apr 28 9:14 PMRA CAPITAL MANAGEMENT, L.P.10% Owner
Other (J)
1,407,000$0.00011,407,000(I)

View →

Apr 21, 2026Apr 22 8:15 PMBAKER BROS. ADVISORS LPDirector, 10% Owner
Purchase
2,252,252$0.000120,105,994(I)

View →

Feb 4, 2026Feb 5 9:14 PMAndrew CombsChief Chemistry Officer
Grant/Award
230,000$2.30230,000(D)

View →

Feb 4, 2026Feb 5 9:12 PMPeggy ScherleChief Scientific Officer
Grant/Award
230,000$2.30230,000(D)

View →

Feb 4, 2026Feb 5 9:11 PMBryant David LimCLO, CFO, Corp Sec.
Grant/Award
275,000$2.30275,000(D)

View →

Feb 4, 2026Feb 5 9:10 PMVaddi KrishnaDirector, CEO
Grant/Award
837,000$2.30837,000(D)

View →